Characteristics | N(%) |
---|---|
Sex | |
Male | 24 (85.7) |
Female | 4 (14.3) |
Age | |
Median | 63 |
Range | 42–77 |
Smoking index | |
0 | 7 (25.0) |
1–400 | 1 (3.6) |
≥ 400 | 20 (71.4) |
KPS status | |
70 | 2 (7.1) |
80 | 16 (57.1) |
90 | 9 (32.1) |
100 | 1 (3.6) |
Weight loss within 6 months before the treatment | |
0 | 19 (67.9) |
<5% | 4 (14.3) |
≥ 5% | 5 (17.9) |
T stage | |
T1 | 1 (3.6) |
T2 | 10 (35.7) |
T3 | 9 (32.1) |
T4 | 8 (28.6) |
N stage | |
N1 | 3 (10.7) |
N2 | 9 (32.1) |
N3 | 16 (57.1) |
Clinical stage | |
IIIA | 7 (25.0) |
IIIB | 21 (75.0) |
Histological type | |
• Squamous cell carcinoma | 15 (53.6) |
Adenocarcinoma | 12 (42.9) |
Neuroendocrine carcinoma | 1 (3.6) |
Inducing chemotherapy before TRT | |
Yes | 17 (60.7) |
No | 11 (39.3) |